The Law Offices of Frank R. Cruz Announces Investigation of MiMedx Group, Inc. (MDXG) on Behalf of InvestorsBusiness Wire • 01/11/24
MIMEDX Provides AXIOFILL® Update & Reiterates 2023 Full Year Net Sales and Fourth Quarter Adjusted EBITDA Margin OutlookGlobeNewsWire • 12/29/23
MIMEDX Announces Conversion of Outstanding Series B Convertible Preferred Stock to Common StockGlobeNewsWire • 12/28/23
MIMEDX to Host Second Quarter 2023 Operating and Financial Results Conference Call on August 1GlobeNewsWire • 07/18/23
MIMEDX Announces Strategic Realignment: Increases Focus on Wound & Surgical Business, Expected to Significantly Improve ProfitabilityGlobeNewsWire • 06/20/23
MIMEDX to Host First Quarter 2023 Operating and Financial Results Conference Call on May 2GlobeNewsWire • 04/18/23
MIMEDX Comments on Recent Data Brief Published by Office of Inspector GeneralGlobeNewsWire • 03/16/23
MIMEDX Announces Fourth Quarter and Full Year 2022 Operating and Financial ResultsGlobeNewsWire • 02/28/23
MIMEDX Confirms Fourth Quarter and Full Year 2022 Net Sales Expectations, Comments on Evolving Medicare Reimbursement Landscape and Provides Corporate UpdatesGlobeNewsWire • 01/09/23
MIMEDX Announces Commercial Launch of EPIFIX® in Japan with Exclusive Distribution Agreement with GUNZE MEDICAL LIMITEDGlobeNewsWire • 01/04/23